Internal Server Error

About BC Advantage Funds

BC Advantage Funds is a venture capital firm founded in 2001. It is primarily based out of Vancouver, Canada. As of Dec 2014, BC Advantage Funds has invested in 14 companies. It primarily invests in Series A round in Canada based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and FinTech. Most recently it participated in the $***** Series D round of Redlen Technologies Overall, BC Advantage Funds portfolio has seen 9 acquisitions including key companies like Aquinox Pharma, Redlen Technologies and Contigo. A lot of funds co-invest with BC Advantage Funds, with names like GrowthWorks Capital sharing a substantial percentage of its portfolio.
Key Metrics
Portfolio Locations
Rounds of Entry
Series A, Series B & 2 more
Portfolio Acquisitions

BC Advantage Funds' List of Top Investments

BC Advantage Funds has a portfolio of 14 companies. Their most notable investmentis in OncoGenex TechnologiesTheir portfolio spans across Canada, United Kingdom and United States. They have invested in Enterprise Applications, Life Sciences, FinTech and 10 other sectors, across stages such as Series A, Series B  and 2 more. Here is the list of top investments by BC Advantage Funds:
Aquinox Pharmaceuticals is a pharmaceutical company developing therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is on anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. Its their lead product candidate is AQX-1125, is a small molecule activator of SHIP1 suitable for oral dosage. AQX-1125 has completed multiple clinical trials and advancing through Phase 3 development in lead indication of bladder pain syndrome/interstitial cystitis (BPS/IC).

Key facts about Aquinox Pharma

  • Founded Year: 2004
  • Location: Vancouver (Canada)
  • Stage: Acquired
  • Total Funding till date: $70.6M
  • Investors: Inbio Ventures, Pfizer and 7 Others
  • Latest Funding Round: Series C, Apr 01, 2013, $*****
  • Highlight: Acquired
Manufacturer of Cadmium Zinc Telluride (CZT) semiconductor radiation imaging modules. These modules are used in medical imaging, security screening, and non-destructive testing applications. The company develops photon counting detector solutions for computed tomography and offers application-specific detector modules. Its manufacturing process combines advanced CZT material with sophisticated electronics. The company's technology is used to create higher-resolution, lower-dose imaging products.

Key facts about Redlen Technologies

Mobidia Technology, Inc. provides a set of mobile app and network usage data solutions to track and benchmark competitors, plan global launch strategies, identify mobile app trends, identify trends for cellular and Wi-Fi, optimize data plans and service offers, develop and optimize over-the-top plans, and target and optimize advertising for businesses. It offers app data, network data, device data, and plan data sets; and methodology, delivery, and dashboard solutions. The company provides real usage data worldwide. Mobidia Technology, Inc. was founded in 2004 and is based in Richmond, Canada. As of May 6, 2015, Mobidia Technology, Inc. operates as a subsidiary of App Annie Limited.

Key facts about Mobidia

Provider of GPS-based location tracking systems. It offers web-based software and a mobile application that enable users to track vehicles, assets, and persons. Its features include real-time tracking, live locations on maps, and notification alerts.

Key facts about Contigo

  • Founded Year: 2002
  • Location: Burnaby (Canada)
  • Stage: Acquired
  • Total Funding till date: $5M
  • Employee Count: 1 - 10 as on Jul 01, 2024
  • Investors: BC Advantage Funds
  • Latest Funding Round: Series B, Jun 06, 2007, $*****
  • Highlight: Acquired
Endurance Wind Power manufactures advanced small wind turbines from 50 to 225kW in size, designed specifically for distributed wind power applications. The company also offers 'Endurance Remote Interface Centre' which is a real time remote monitoring system for the turbines.

Key facts about Endurance Wind Power

BC Advantage Funds' Investments by Stage

BC Advantage Funds has made 6 investments in Series A stage with an average round size of $7.68M, 4 investments in Series B stage with an average round size of $15.1M, 1 investment in Seed stage with an average round size of $500K and 1 investment in Series C stage with an average round size of $7.8M.
Here are BC Advantage Funds' investments by stage:
Stage of entry
No. of Investments
Series A
6
Series B
4
Seed
1
Series C
1
Breakdown of BC Advantage Funds' investments by stage of entrySeries A (6)Series B (4)
Note: We have considered here, only first round of investments

BC Advantage Funds' Investments by Sector

BC Advantage Funds has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, Chemicals and Materials, Consumer and Energy. Notably, it has invested in 11 Tech companies, 9 Enterprise (B2B) companies, 6 Software companies and at least 4 companies focusing on Consumer (B2C).
Here are BC Advantage Funds' investments by sector:
Sector
No. of Investments
Life Sciences
5
Enterprise Applications
2
Chemicals and Materials
1
Consumer
1
Energy
1
Others
8
Breakdown of BC Advantage Funds' investments by sectorsLife Sciences (5)Enterprise Applic... (2)
Note: We have considered here, only first round of investments

BC Advantage Funds' Investments by Geography

BC Advantage Funds has made most investments in Canada (11), followed by United Kingdom where it has made 1 investment.
Here are BC Advantage Funds' investments by geography:
Country
No. of Investments
Canada
11
United Kingdom
1
Breakdown of BC Advantage Funds' investments by countriesCanada (11)United Kingdom (1)
Note: We have considered here, only first round of investments

BC Advantage Funds' recent investments

BC Advantage Funds has not made any investment in 2026 so far.
Here are the most recent investments by BC Advantage Funds:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Dec 01, 2014
Canada
Series D
3632
-
Sep 29, 2011
Canada
Series A
6821
  [+1]
Jan 17, 2011
Canada
Series A
9584
-
Jun 17, 2010
Canada
Series B
6498
  [+2]
2010
Canada
Series A
4809

Acquired companies in BC Advantage Funds' Portfolio

9 companies from BC Advantage Funds' portfolio have been acquired. The most recent acquisition were Redlen Technologies in Sep 2021 by Canon for $335M.
Here are BC Advantage Funds' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Sep 09, 2021
Feb 09, 2010
Series C
2562
Jul 29, 2020
Jun 12, 2007
Series A
3777
Mar 03, 2016
Jun 06, 2007
Series B
9794
Apr 01, 2015
Jul 14, 2005
Series A
9056
Jan 26, 2014
-
-
4364

Co-investors of BC Advantage Funds

Over the past 22 years, 35 investors have co-invested in BC Advantage Funds's portfolio companies. This includes only funds.

  • Invested before BC Advantage FundsYaletown, BDC and 4 others have invested in rounds before BC Advantage Funds. There are 3 companies where Yaletown has invested before BC Advantage Funds and 2 companies where BDC has invested before BC Advantage Funds.
  • Top Co-investors of BC Advantage Funds16 investors entered a company along with BC Advantage Funds. These include investors like GrowthWorks Capital (3 companies).
  • Invested after BC Advantage FundsA total of 13 investors have invested in BC Advantage Funds's portfolio after their investments. Top Investors include Pfizer (1 company), Augment Investments (1 company) and Johnson & Johnson Innovation (1 company).

Recent News related to BC Advantage Funds

PR NewswireJun 12, 2007Aquinox Pharma, Ventures West, JJDC, BC Advantage Funds and 1 other
View all news related to BC Advantage Funds

FAQs about BC Advantage Funds

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford